Posts by: admin

News

According to a study from UCLA’s Jonsson Comprehensive Cancer Center researchers, children whose progenitors survived melanoma are not adequately using sun protection. This is especially alarming, as these children have ... Read more

January 14, 2015January 14, 2015

Novel Mechanism Behind Melanoma Drug Resistance Unveiled

News

Recent research has unveiled the mechanisms responsible for targeted therapy resistance in melanoma patients. This type of therapy has a lower toxicity rate and can improve results for different types ... Read more

January 9, 2015January 9, 2015

New Mouse Cell Line To Study BRAF Melanoma

News

A team of Dartmouth scientists has developed a cell line that can be used as a research tool for investigators using mice models of melanoma. In the study, published in ... Read more

January 5, 2015January 5, 2015

Researchers Identify Gene Mutations Involved In Majority Of Melanomas

News

Recent research from the University of Louisville’s James Graham Brown Cancer Center has identified mutations responsible for DNA structure alterations that turn off genes located at four different sites of ... Read more

December 26, 2014December 26, 2014

Researchers Identify Protein Involved In Melanoma Metastasis Into The Lung

News

In a recent study titled “Role of Chitinase 3-like-1 and Semaphorin 7A in Pulmonary Melanoma Metastasis”, published in Cancer Research, a team of researchers from Brown and Yale University found ... Read more

December 22, 2014December 22, 2014

Airline Pilots Are Exposed To High Levels of UV-A Cockpit Radiation

News

A group of researchers from the University of California published a recent research letter in JAMA Dermatology whereby they state airline pilots could be exposed to the same levels of ... Read more

December 18, 2014December 18, 2014

New Drugs To Treat Drug Resistant Melanoma Discovered by Researchers

News

In a recent study published in the journal Cancer Cell scientists at The Institute of Cancer Research, London, and the Cancer Research UK Manchester Institute, found a new family of drugs, ... Read more

December 17, 2014December 17, 2014

Study Finds Hair Shaft miRNA-221 Levels Can Be Used As Malignant Melanoma Biomarker

News

In a recent study titled “Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma”, published in The Journal of Dermatology, a team of researchers from Kumamoto University, Japan, ... Read more

December 16, 2014December 16, 2014

Study Evaluates Number of Nevi Biopsies in U.S. Children

News

In a recent research letter titled “Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013”, published in Jama Dermatology, a group of scientists led by ... Read more

December 15, 2014December 15, 2014

Study Finds Firefighters Have Increased Risk of Melanoma

News

A study led by Monash University researchers found that firefighters have an increased risk of developing melanoma and prostate cancer when compared to the general public. The analysis, appointed by ... Read more

December 11, 2014December 11, 2014

Study Finds IL-17 and IL-22 Influence Non-Melanoma Skin Cancer Growth

News

In a recent study titled “Interleukin-17 and Interleukin-22 promote tumor progression in human non-melanoma skin cancer”, published ahead of print in the European Journal of Immunology, a group of researchers from ... Read more

December 10, 2014December 10, 2014

Amgen Begins Clinical Trial To Evaluate Talimogene Laherparepvec In Combination With KEYTRUDA For Advanced Melanoma

News

Amgen has announced it will initiate a clinical trial of talimogene laherparepvec, an investigational immunotherapy, in combination with Merck’s KEYTRUDA (pembrolizumab), in patients diagnosed with regionally or distantly metastatic melanoma. ... Read more

December 9, 2014December 9, 2014

Study Reviews The Use Of Melanoma Chemopreventive Agents

News

Even though there have been significant advances in drug discovery and molecular research to identify drug targets, the incidence and mortality rates associated with melanoma have been continuously rising. Commonly ... Read more

December 8, 2014December 8, 2014

Array Signed Agreement To Regain Worldwide Rights To Binimetinib

News

Array BioPharma Inc. has announced it reached a conclusive agreement with Novartis allowing it to recover complete worldwide rights to binimetinib, a MEK inhibitor currently being investigated in three Phase ... Read more

December 5, 2014December 5, 2014

Study Finds Proteomic Biomarkers in Metastatic Melanoma

News

In a recent study titled “Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation”, published in the PlosOne journal, a team of researchers led by Dr. Vito ... Read more

December 4, 2014

Study Finds Combined PV-10 And Immune Checkpoint Inhibitors Efficient In Melanoma Treatment

News

During the 29th annual meeting of the Society for Immunotherapy of Cancer, Dr. Shari Pilon-Thomas of the Moffitt Cancer Center, presented a study titled “Efficacy of Intralesional Injection with PV-10 ... Read more

December 3, 2014December 3, 2014

Study Finds TERT Mutations Could Predict Survival Outcome in Melanoma Patients

News

In a recent study titled “TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma”, published in the Journal of the National Cancer Institute (JNCI), a group of researchers ... Read more

December 2, 2014

Study Finds immunoSEQ Assay Could Be Used to Predict Pembrolizumab Response in Melanoma Patients

News

A recent study published in Nature, successfully demonstrated that Adaptive Biotechnologies’s immunoSEQ Assay could aid in the identification of patients suffering from metastatic melanoma who are more likely to respond ... Read more

December 1, 2014December 1, 2014

Study Investigates Potent Cancer Vaccine

News

Recent research developed by scientists at the Washington University School of Medicine in St. Louis, titled “Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens” and published in the prestigious Nature ... Read more

November 28, 2014November 28, 2014

Study Finds Mechanism Behind Melanoma Patients’ Response to Pembrolizumab

News

Recent work supported by the Stand Up To Cancer (SU2C) – Cancer Research Institute (CRI) – Immunology Translational Research Dream Team, was published ahead of print in the prestigious Nature ... Read more